SILO PHARMA, INC. Accounts Payable and Other Accrued Liabilities, Current
SILO PHARMA, INC. (SILO) had Accounts Payable and Other Accrued Liabilities, Current of $92.09 thousand as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2023-11-13
- 2023-09-30: Accounts Payable and Other Accrued Liabilities, Current $92.09K.
- 2022-12-31: Accounts Payable and Other Accrued Liabilities, Current $92.09K.
| Period end | Accounts Payable and Other Accrued Liabilities, Current |
|---|---|
| 2023-09-30 | $92.09K 10-Q · filed 2023-11-13 |
| 2022-12-31 | $92.09K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |